StevenPaulMargossianMD
Pediatric Hematology & Oncology • Boston, MAPediatric Hematologic Oncology
Assistant Professor of Pediatrics, Harvard Medical School
Dr. Margossian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana
Boston, MA 02115Phone+1 617-632-6793Fax+1 617-632-4410
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2000 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1997 - 2000
University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
MA State Medical License 2000 - 2025
NY State Medical License 1998 - 2000- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 157 citationsToxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P. Margossian, Nancy A. Kernan, Lewis B. Silverman, David A. Williams
Blood. 2019-12-26 - 207 citationsCdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitorsSofia B. Lizarraga, Steven P. Margossian, Marian H. Harris, Dean R. Campagna, An-Ping Han
Development. 2010-06-01 - 80 citationsDisease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen R...Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips
Journal of Clinical Oncology. 2022-03-20
Abstracts/Posters
- Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALLSteven P. Margossian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...Steven P. Margossian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- Defining The Role Of FANCD2 In Homology-Directed DNA RepairNational Heart, Lung, And Blood Institute2007–2009
- Defining The Role Of FANCD2 In Homology-Directed DNA RepairNational Heart, Lung, And Blood Institute2005–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
